Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol
Introduction
There is increasing evidence to suggest that ethanol may affect the central nervous system (CNS) by interfering with amino acid neurotransmitter systems. Among the amino acid neurotransmitter systems are excitatory amino acids (aspartate and glutamate) that activate postsynaptic cells and the inhibitory amino acids (GABA and taurine) that depress the activity of the postsynaptic cells. Glutamate is the major neuroexcitatory amino acid in the CNS. It activates receptors, which are gated to ion channels or activates proteins mediating a second messenger. This neurotransmitter has been reported to play an important role in alcoholism (Tsai et al., 1995, Tsai et al., 1998). Glutamate receptors in the mammalian CNS are divided into ionotropic (NMDA, kainate, and AMPA) and metabotropic receptors. The NMDA receptor, which is coupled to a voltage-sensitive ion channel, is permeable to calcium and monovalent cations Na+ and K+, and has been implicated in many physiological and pathological processes, including synaptic plasticity, learning and memory, epileptiform seizures, and neurotoxicity.
Section snippets
Acute effect of ethanol
A decrease in glutamate extracellular striatal concentration occurred in an in vivo microdialysis study after administration of 2 g/kg ethanol (Carboni, Isola, Gessa, & Rossetti, 1993), while another microdialysis study showed a biphasic response with either 0.5 (increase) or 2 g/kg (decrease) ethanol on the glutamate release in both hippocampus and nucleus accumbens regions (Moghaddam & Bolinao, 1994). Ethanol appears to be less potent in inhibiting the non-NMDA ionotropic glutamate receptors (
Ethanol withdrawal
Cessation of CET leads to seizures, hyperexcitability, and ethanol withdrawal. Animal studies have revealed that overactivation of glutamate receptors contribute to the generation of these symptoms (Grant et al., 1990, Gulya et al., 1991) and could lead to excitotoxicity death (Davidson et al., 1995, Iorio et al., 1993). Human studies have indicated that excitatory neurotransmitters were elevated in the cerebrospinal fluid of alcohol-dependent patients and a positive correlation between
Multiple ethanol withdrawal
Because multiple and repeated periods of chronic ethanol consumption and withdrawal often occur in alcohol abusers, the study in animal models of the glutamate changes following CET interrupted by repeated ethanol withdrawal episodes will be of clinical relevance for the development of treatment strategies. The hippocampus could be expected to play an important role during detoxification because this brain region has been implicated in anxiety and seizures (Gray, 1982), which are typically
Acamprosate and repeated ethanol withdrawal
Pharmacological agents for the treatment of alcoholism are an important part of the treatment plan for dependent chronic alcohol abusers that includes substantial education, psychological therapy, and social support. Many drugs have been developed during the last decade to combat the side effects induced by chronic alcohol abuse, such as alcohol withdrawal, craving, and relapse related to alcohol abuse, as well as drugs to decrease alcohol intake. Among the drugs currently used for the
Conditioning associated with ethanol
Excitatory amino acids neurotransmission has been implicated in learning associations between external stimuli and intrinsic reward value, such that it may play a key role in conditioned drug effects. The amygdala is a key component of the limbic system, and is involved in emotion, motivation, learning, and memory (Fig. 6). The amygdaloid complex receives sensory information from other brain regions, such as visually related areas, olfactory information, and taste. Much of the sensory
Clinical implications
- (1)
During ethanol withdrawal, a dramatic increase of glutamate was reported; glutamate is involved in learning, memory, and control of behavior, indicating that every stimulus occurring during withdrawal will be memorized and learned more efficiently. Thus, the withdrawal period seems appropriate for patients to learn new strategies to avoid relapse.
- (2)
Repeated withdrawals lead to exacerbation of the glutamate increase observed after one withdrawal. Too much glutamate may induce excitotoxicity and
References (59)
- et al.
Repeated ethanol withdrawal increases the severity and duration of subsequent withdrawal seizures in mice
Alcohol
(1997) - et al.
Ethanol prevents the glutamate release induced by N-methyl-d-aspartate in the rat striatum
Neuroscience Letters
(1993) - et al.
Excitatory amino acid changes during repeated episodes of ethanol withdrawal: An in vivo microdialysis study
European Journal of Pharmacology
(2003) - et al.
Central effect of acamprosate: Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate during ethanol withdrawn rats
Psychiatry Research. Neuroimaging Section
(1998) - et al.
Taurine increases in the nucleus accumbens microdialysate after acute ethanol administration to naïve and chronically alcoholised rats
Brain Research
(1996) - et al.
Increased NMDA-induced excitability during ethanol withdrawal: A behavioural and histological study
Brain Research
(1995) - et al.
Increased sensitivity of the hippocampus in ethanol dependent rats to toxic effect of N-methyl-d-aspartic acid in vivo
Brain Research
(1993) - et al.
Ethanol-withdrawal seizures and the NMDA receptor complex
European Journal of Pharmacology
(1990) - et al.
Ethanol-induced components of 45Ca++ uptake in PC 12 cells is sensitive to Ca++ channel modulating drugs
Brain Research
(1987) - et al.
Selective inhibition by ethanol of glutamate-stimulated cyclics GMP production in primary cultures of cerebellar granule cells
Neuropharmacology
(1989)